Abnormal cellular accumulation of the dicarbonyl metabolite MG (methylglyoxal) occurs on exposure to high glucose concentrations, inflammation, cell aging and senescence. It is associated with increased MG-adduct content of protein and DNA linked to increased DNA strand breaks and mutagenesis, mitochondrial dysfunction and ROS (reactive oxygen species) formation and cell detachment from the extracellular matrix. MG-mediated damage is countered by glutathione-dependent metabolism by Glo1 (glyoxalase 1). It is not known, however, whether Glo1 has stress-responsive up-regulation to counter periods of high MG concentration or dicarbonyl stress. We identified a functional ARE (antioxidant-response element) in the 5′-untranslated region of exon 1 of the mammalian Glo1 gene. Transcription factor Nrf2 (nuclear factor-erythroid 2 p45 subunit-related factor 2) binds to this ARE, increasing basal and inducible expression of Glo1. Activators of Nrf2 induced increased Glo1 mRNA, protein and activity. Increased expression of Glo1 decreased cellular and extracellular concentrations of MG, MG-derived protein adducts, mutagenesis and cell detachment. Hepatic, brain, heart, kidney and lung Glo1 mRNA and protein were decreased in Nrf2−/− mice, and urinary excretion of MG protein and nucleotide adducts were increased approximately 2-fold. We conclude that dicarbonyl stress is countered by up-regulation of Glo1 in the Nrf2 stress-responsive system, protecting protein and DNA from increased damage and preserving cell function.
Skip Nav Destination
Article navigation
April 2012
- Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
Research Article|
March 14 2012
Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycation
Mingzhan Xue;
Mingzhan Xue
*Clinical Sciences Research Laboratories, Warwick Medical School, University of Warwick, University Hospital, Coventry CV2 2DX, U.K.
Search for other works by this author on:
Naila Rabbani;
Naila Rabbani
*Clinical Sciences Research Laboratories, Warwick Medical School, University of Warwick, University Hospital, Coventry CV2 2DX, U.K.
†Warwick Systems Biology Centre, Coventry House, University of Warwick, Coventry CV4 7AL, U.K.
Search for other works by this author on:
Hiroshi Momiji;
Hiroshi Momiji
†Warwick Systems Biology Centre, Coventry House, University of Warwick, Coventry CV4 7AL, U.K.
Search for other works by this author on:
Precious Imbasi;
Precious Imbasi
1
‡Department of Biological Sciences, University of Essex, Wivenhoe Park, Colchester, Essex CO4 3SQ, U.K.
Search for other works by this author on:
M. Maqsud Anwar;
M. Maqsud Anwar
*Clinical Sciences Research Laboratories, Warwick Medical School, University of Warwick, University Hospital, Coventry CV2 2DX, U.K.
Search for other works by this author on:
Neil Kitteringham;
Neil Kitteringham
§MRC Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool L69 3GE, U.K.
Search for other works by this author on:
B. Kevin Park;
B. Kevin Park
§MRC Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool L69 3GE, U.K.
Search for other works by this author on:
Tomokazu Souma;
Tomokazu Souma
‖Department of Medical Biochemistry, Tohoku University Graduate School of Medicine, 2-1 Seiryo-cho, Aoba-ku, Sendai 980-8575, Japan
Search for other works by this author on:
Takashi Moriguchi;
Takashi Moriguchi
‖Department of Medical Biochemistry, Tohoku University Graduate School of Medicine, 2-1 Seiryo-cho, Aoba-ku, Sendai 980-8575, Japan
Search for other works by this author on:
Masayuki Yamamoto;
Masayuki Yamamoto
‖Department of Medical Biochemistry, Tohoku University Graduate School of Medicine, 2-1 Seiryo-cho, Aoba-ku, Sendai 980-8575, Japan
Search for other works by this author on:
Paul J. Thornalley
Paul J. Thornalley
2
*Clinical Sciences Research Laboratories, Warwick Medical School, University of Warwick, University Hospital, Coventry CV2 2DX, U.K.
†Warwick Systems Biology Centre, Coventry House, University of Warwick, Coventry CV4 7AL, U.K.
‡Department of Biological Sciences, University of Essex, Wivenhoe Park, Colchester, Essex CO4 3SQ, U.K.
2To whom correspondence should be addressed (email P.J.Thornalley@warwick.ac.uk).
Search for other works by this author on:
Biochem J (2012) 443 (1): 213–222.
Article history
Received:
September 12 2011
Revision Received:
December 20 2011
Accepted:
December 22 2011
Accepted Manuscript online:
December 22 2011
Citation
Mingzhan Xue, Naila Rabbani, Hiroshi Momiji, Precious Imbasi, M. Maqsud Anwar, Neil Kitteringham, B. Kevin Park, Tomokazu Souma, Takashi Moriguchi, Masayuki Yamamoto, Paul J. Thornalley; Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycation. Biochem J 1 April 2012; 443 (1): 213–222. doi: https://doi.org/10.1042/BJ20111648
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.